CompanyIt's our mission to have a turnkey solution for bringing drugs to targeted cells

It's our mission to have a turnkey solution for bringing drugs to targeted cells

Team

Pioneering in the field of Fibrobody-Drug Conjugates

More on Team

Our multidisciplinary team comprises chemists, biologists, biotechnicians and drug development specialists 

Location and facilities

More on Location and facilities
Careers

We are always in search of new colleagues

More on Careers

We are the first to develop Fibrobodies® and Fibrobody®-Drug Conjugates to diagnose and combat liver fibrosis and other fibrotic diseases.

What’s new at LinXis

Image LinXis attends EANM
Event

LinXis attends EANM

17 October 2024

LinXis will attend EANM in Hamburg from October 19-23, where we will also present the preclinical results-to-date on our lead Fibrobody® in a Top Rated Oral Presentation.
Image LinXis publishes key paper on lead Fibrobody® in EJNMMI
Publication

LinXis publishes key paper on lead Fibrobody® in EJNMMI

18 June 2024

Read all about the preclinical validation of our lead Fibrobody® in the European Journal of Nuclear Medicine and Molecular Imaging.
Image Guus van Dongen joins LinXis as Chief Scientific Officer
Team

Guus van Dongen joins LinXis as Chief Scientific Officer

1 January 2024

We are proud to welcome Guus van Dongen as our full-time CSO.